ALCAM and inflammatory bowel disease: In autoimmunity, CD166 has been implicated in the pathogenesis of lupus nephritis, rheumatoid arthritis, Sjogren’s syndrome, and inflammatory bowel disease in which both CD6 and CD166 are overexpressed (28, 31, 32, 48).